68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression

  • Clemens Decristoforo
  • Ignacio Hernandez Gonzalez
  • Janette Carlsen
  • Marco Rupprich
  • Marc Huisman
  • Irene Virgolini
  • Hans-Jürgen Wester
  • Roland Haubner
Original article

DOI: 10.1007/s00259-008-0757-6

Cite this article as:
Decristoforo, C., Hernandez Gonzalez, I., Carlsen, J. et al. Eur J Nucl Med Mol Imaging (2008) 35: 1507. doi:10.1007/s00259-008-0757-6

Abstract

Purpose

αvβ3 integrins are important cell adhesion receptors involved in angiogenic processes. Recently, we demonstrated using [18F]Galacto-RGD that monitoring of αvβ3 expression is feasible. Here, we introduce 68Ga- and 111In-labelled derivatives and compare them with [18F]Galacto-RGD.

Methods

For radiolabelling, cyclo(RGDfK(DOTA)) was synthesised using SPPS. For in vitro characterisation determination of partition coefficients, protein binding, metabolic stability, αvβ3 affinity and cell uptake and for in vivo characterization, biodistribution studies and micro positron emission tomography (PET) imaging were carried out. For in vivo and in vitro studies, human melanoma M21 (αvβ3 positive) and M21-L (αvβ3 negative) cells were used.

Results

Both tracers can be synthesised straightforward. The compounds showed hydrophilic properties and high metabolic stability. Up to 23% protein-bound activity for [68Ga]DOTA-RGD and only up to 1.4% for [111In]DOTA-RGD was found. Cell uptake studies indicate receptor-specific accumulation. This is confirmed by the biodistribution data. One hour p.i. accumulation in αvβ3-positive tumours was 2.9 ± 0.3%ID/g and in αvβ3-negative tumours 0.8 ± 0.1%ID/g for [68Ga]DOTA-RGD ([111In]DOTA-RGD: 1.9 ± 0.3%ID/g and 0.5 ± 0.2%ID/g; [18F]Galacto-RGD: 1.6 ± 0.2%ID/g and 0.4 ± 0.1%ID/g). Thus, tumour uptake ratios were comparable. Due to approx. 3-fold higher blood pool activities for [68Ga]DOTA-RGD, tumour/blood ratios were higher for [111In]DOTA-RGD and [18F]Galacto-RGD. However, microPET studies demonstrated that visualisation of αvβ3-positive tumours using [68Ga]DOTA-RGD is possible.

Conclusions

Our data indicate that [68Ga]DOTA-RGD allows monitoring of αvβ3 expression. Especially, the much easier radiosynthesis compared to [18F]Galacto-RGD would make it an attractive alternative. However, due to higher blood pool activity, [18F]Galacto-RGD remains superior for imaging αvβ3 expression. Introduction of alternative chelator systems may overcome the disadvantages.

Keywords

Ga-68 RGD-peptides αvβ3 Molecular imaging Angiogenesis 

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Clemens Decristoforo
    • 1
  • Ignacio Hernandez Gonzalez
    • 1
  • Janette Carlsen
    • 2
  • Marco Rupprich
    • 1
  • Marc Huisman
    • 2
  • Irene Virgolini
    • 1
  • Hans-Jürgen Wester
    • 2
  • Roland Haubner
    • 1
    • 3
  1. 1.Department of Nuclear MedicineMedizinische Universität InnsbruckInnsbruckAustria
  2. 2.Department of Nuclear MedicineTechnische Universität MünchenMunichGermany
  3. 3.Universitätsklinik für NuklearmedizinMedizinische Universität InnsbruckInnsbruckAustria

Personalised recommendations